2.5800
-0.2300
(-8.19%)
At close: April 8 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.49 | -0.53 | -1.99 | -0.95 |
| Low Estimate | -0.49 | -0.53 | -2.11 | -1.14 |
| High Estimate | -0.49 | -0.53 | -1.86 | -0.77 |
| Year Ago EPS | -0.51 | -- | -1.93 | -1.99 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.43 | -0.55 | -0.56 | -0.51 |
| EPS Actual | -0.51 | -0.46 | -0.42 | -0.54 |
| Difference | -0.08 | 0.09 | 0.14 | -0.03 |
| Surprise % | -18.60% | 16.36% | 25.00% | -5.88% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.49 | -0.53 | -1.99 | -0.95 |
| 7 Days Ago | 0 | 0 | -1.74 | -1.14 |
| 30 Days Ago | 0 | 0 | -1.74 | -1.14 |
| 60 Days Ago | 0 | 0 | -1.74 | -1.14 |
| 90 Days Ago | 0 | 0 | -1.74 | -1.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LTRN | 3.92% | -- | -2.85% | 51.89% |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Initiated | Lake Street: Buy | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Neutral | 4/25/2024 |
| Reiterates | EF Hutton: Buy to Buy | 8/10/2023 |
| Maintains | EF Hutton: Buy to Buy | 6/26/2023 |
| Initiated | HC Wainwright & Co.: Neutral | 5/18/2023 |
| Reiterates | EF Hutton: Buy | 3/21/2023 |
Related Tickers
OSTX OS Therapies Incorporated
1.3100
-8.39%
ACTU Actuate Therapeutics, Inc. Common stock
6.97
+2.20%
INAB IN8bio, Inc.
0.1499
+1.15%
IPSC Century Therapeutics, Inc.
0.3891
-5.58%
KAPA Kairos Pharma, Ltd.
0.9676
-15.13%
IOBT IO Biotech, Inc.
0.8322
-8.55%
NRXP NRx Pharmaceuticals, Inc.
1.7100
-5.52%
AZTR Azitra, Inc.
0.2764
-2.06%
RENB Renovaro Inc.
0.4039
-6.94%
GBIO Generation Bio Co.
0.3240
-13.69%